Opportunistic pricing: a new scourge, a new call for action.
D019380:Anti-HIV Agents / Q000191:economics*; D016527:Drug Costs; D004345:Drug Industry; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000191:economics*; D006801:Humans; D010344:Patient Advocacy; D018894:Reverse Transcriptase Inhibitors / Q000191:economics*; D014481:United States
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors